Lynparza 150 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ5E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,485
Award facts
- Contract value 100% obligated
- $54,484.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $54,484.96 to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120-count units). This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 4, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal military and veteran healthcare systems.
Lynparza is an oncology medication used in cancer treatment, reflecting DLA's ongoing requirement to supply specialized pharmaceutical products across multiple therapeutic domains to support military treatment facilities and defense health programs. This delivery order exemplifies the routine execution of task orders under DLA's pharmaceutical prime vendor contracts, which enable efficient procurement of both brand-name and generic medications, vaccines, and medical supplies necessary for global military healthcare operations. The non-set-aside, competitively awarded nature of this order underscores AmerisourceBergen's established capability to meet federal pharmaceutical procurement standards through open competition.
Quick answers
Who was awarded contract SPE2DR26FCZ5E?
SPE2DR26FCZ5E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FCZ5E worth?
The government has obligated $54,485 on SPE2DR26FCZ5E.
Is contract SPE2DR26FCZ5E an order under another contract?
Yes. SPE2DR26FCZ5E is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ5E competed?
The extent of competition for SPE2DR26FCZ5E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award